Top Markets
Coin of the day
Pulse Biosciences, Inc. Pulse Biosciences, Inc.

Pulse Biosciences, Inc.

PLSE
Clasificación en acciones #4732
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Precio por acción
$48.46
Capitalización bursátil
$3.35B
Cambio (1 día)
-1.09%
Cambio (1 año)
186.60%
País
US
Comercio Pulse Biosciences, Inc. (PLSE)

Categoría

Ratio P/B de Pulse Biosciences, Inc. (PLSE)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Pulse Biosciences, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Pulse Biosciences, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
7.6976 -
US
1.9116 -
FR
- -
JP
2.0641 -
US
- -
CH